Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases? Response

被引:0
|
作者
Nathan, Steven D. [1 ]
Shen, Eric
Deng, Chunqin [2 ]
机构
[1] Inova Fairfax Hosp, Adv Lung Dis & Lung Transplant Program, Falls Church, VA 22042 USA
[2] United Therapeut Corp, Silver Spring, MD USA
关键词
D O I
10.1016/j.chest.2024.01.004
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:e162 / e162
页数:1
相关论文
共 50 条
  • [1] Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases?
    Genecand, Leon
    Lador, Frederic
    Montani, David
    Perneger, Thomas
    [J]. CHEST, 2024, 165 (05) : e161 - e161
  • [2] DOSE RESPONSE ANALYSIS OF INHALED TREPROSTINIL IN PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND ITS EFFECTS ON CLINICAL WORSENING
    Waxman, Aaron
    Nathan, Steven
    Fisher, Micah
    Ford, H. James
    Gagermeier, James
    Parambil, Joseph
    Raina, Amresh
    Zwicke, Dianne
    Gerke, Alicia
    Shen, Eric
    Lee, Dasom
    Rao, Youlan
    Tapson, Victor
    [J]. CHEST, 2021, 160 (04) : 2279A - 2280A
  • [3] Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
    Waxman, Aaron
    Restrepo-Jaramillo, Ricardo
    Thenappan, Thenappan
    Ravichandran, Ashwin
    Engel, Peter
    Bajwa, Abubakr
    Allen, Roblee
    Feldman, Jeremy
    Argula, Rahul
    Smith, Peter
    Rollins, Kristan
    Deng, Chunqin
    Peterson, Leigh
    Bell, Heidi
    Tapson, Victor
    Nathan, Steven D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (04): : 325 - 334
  • [4] Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
    Faria-Urbina, Mariana
    Oliveira, Rudolf K. F.
    Agarwal, Manyoo
    Waxman, Aaron B.
    [J]. LUNG, 2018, 196 (02) : 139 - 146
  • [5] Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
    Mariana Faria-Urbina
    Rudolf K. F. Oliveira
    Manyoo Agarwal
    Aaron B. Waxman
    [J]. Lung, 2018, 196 : 139 - 146
  • [6] Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension
    Parikh, Kishan S.
    Rajagopal, Sudarshan
    Fortin, Terry
    Tapson, Victor F.
    Poms, Abby D.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2016, 67 (04) : 322 - 325
  • [7] COMPARISON OF EFFECTS OF INHALED TREPROSTINIL ON LUNG FUNCTION IN PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND PULMONARY ARTERIAL HYPERTENSION
    Nathan, Steven
    Tapson, Victor
    Ramani, Gautam
    Medarov, Boris
    Levine, Deborah
    Burger, Charles
    El-Kersh, Karim
    Shen, Eric
    Rao, Youlan
    Smith, Peter
    Waxman, Aaron
    [J]. CHEST, 2021, 160 (04) : 2244A - 2246A
  • [8] Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease
    Sakao, Seiichiro
    Kondoh, Yasuhiro
    Kinoshita, Hideyuki
    Nishiyama, Osamu
    Ogo, Takeshi
    Tanabe, Nobuhiro
    Minatsuki, Shun
    Nakayama, Kazuhiko
    Taniguchi, Yu
    Takahashi, Kenta
    Takatsu, Masahiro
    Ogura, Takashi
    [J]. RESPIRATORY INVESTIGATION, 2024, 62 (06) : 980 - 986
  • [9] Inhaled Treprostinil in Pulmonary Hypertension in the Context of Interstitial Lung Disease: A Success, Finally
    Behr, Juergen
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (02) : 144 - 146
  • [10] Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
    Raina, Amresh
    Coons, James C.
    Kanwar, Manreet
    Murali, Srinivas
    Sokos, George
    Benza, Raymond L.
    [J]. PULMONARY CIRCULATION, 2013, 3 (01) : 116 - 120